Author contributions:All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership:None declared.
Honorarium: None declared.
Competing interests:The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Mårtensson O, Härlin A, Brandt R, Seppä K, Sillanaukee P. Transferrin isoform distribution: gender and alcohol consumption. Alcohol Clin Exp Res 1997;21:1710–15.10.1111/j.1530-0277.1997.tb04512.xSearch in Google Scholar
2. Jeppsson JO, Arndt T, Schellenberg F, Wielders JP, Anton RF, Whitfield JB, et al. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 2007;45:558–62.10.1515/CCLM.2007.107Search in Google Scholar PubMed
3. Helander A, Eriksson G, Stibler H, Jeppsson J-O. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 2001;47:1225–33.10.1093/clinchem/47.7.1225Search in Google Scholar
4. Portman M, Penttila A, Haukka J, Eriksson P, Alho H, Kuoppasalmi K. Predicting DUI recidivism of male drunken driving: a prospective study of the impact of alcohol markers and previous drunken driving. Drug Alcohol Depend 2010;106:186–92.10.1016/j.drugalcdep.2009.08.018Search in Google Scholar PubMed
5. Bortolotti F, Micciolo R, Canal L, Tagliaro F. First objective association between elevated carbohydrate-deficient transferrin concentrations and alcohol-related traffic accidents. Alcohol Clin Exp Res 2015;39:2108–14.10.1111/acer.12879Search in Google Scholar PubMed
6. Appenzeller BM, Wennig R. Altered distribution of transferrin isoforms according to serum Sorage conditions. Clin Chem 2005;51:2159–62.10.1373/clinchem.2005.050203Search in Google Scholar PubMed
7. Helander A, Husa A, Jeppsson JO. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 2003;49:1881–90.10.1373/clinchem.2003.023341Search in Google Scholar PubMed
8. Arndt T, Hackler R, Müller T, Kleine TO, Gressner AM. Increased serum concentration of carbohydrate deficient transferrin in patients with combined pancreas and kidney transplantation. Clin Chem 1997;43:344–51.10.1093/clinchem/43.2.344Search in Google Scholar
9. Mårtensson O, Schink E, Brandt R. Diurnal variability and in vitro stability of carbohydrate-deficient transferrin. Clin Chem 1998;44:2226–27.10.1093/clinchem/44.10.2226Search in Google Scholar
10. Bergström JP, Helander A. HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels. Clin Chim Acta 2008;389:164–66.10.1016/j.cca.2007.11.020Search in Google Scholar PubMed
©2016 Walter de Gruyter GmbH, Berlin/Boston